Stay updated on DTX301 Clinical Trial in Late-Onset OTC Deficiency
Sign up to get notified when there's something new on the DTX301 Clinical Trial in Late-Onset OTC Deficiency page.
Latest updates to the DTX301 Clinical Trial in Late-Onset OTC Deficiency page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedFooter revision tag updated from v3.3.1 to v3.3.2, indicating a minor site update with no changes to study details or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check16 days agoChange DetectedThe page now displays Revision: v3.3.1, replacing the previous Revision: v3.2.0.SummaryDifference0.1%
- Check23 days agoChange DetectedDeleted the government funding status notice from the page. Core study details, eligibility criteria, locations, and outcome measures remain unchanged.SummaryDifference0.4%
- Check38 days agoChange DetectedNo significant changes to the study details were detected; the page content remains focused on safety and dose-finding of DTX301 with the same eligibility criteria, study arms, and outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check67 days agoChange DetectedTerminology updated from “Urea cycle disorder” to “Disorder of the urea cycle metabolism” and version bumped from v3.0.2 to v3.2.0; core topic remains but with more precise naming and a new release version.SummaryDifference0.3%
- Check68 days agoChange DetectedOverall, the page updates its terminology from “Urea cycle disorder” to “Disorder of the urea cycle metabolism” and advances the revision to v3.1.0, signaling a broader description and a new version.SummaryDifference0.3%
Stay in the know with updates to DTX301 Clinical Trial in Late-Onset OTC Deficiency
Enter your email address, and we'll notify you when there's something new on the DTX301 Clinical Trial in Late-Onset OTC Deficiency page.